Gilead warns against Hep C drugs from buyers clubs, says patients may be at risk

California-headquartered Gilead Sciences has warned against the use of generic versions of its blockbuster Hepatitis C drugs procured by patients directly through “buyers clubs.” A disruptive phenomenon, dozens of buyers clubs have mushroomed in recent years that enable supply of generic lifesaving medicines to thousands of patients afflicted with the fatal liver ailment. In its latest May 9 regulatory filings in Form 10K at the US Securities Exchange Com

Generic hepatitis C drugs continue to produce high cure rates

Treatment with generic versions of direct-acting antiviral drugs continues to produce similar cure rates to those reported in clinical trials, Dr James Freeman reported last week at the International Liver Congress in Amsterdam. Dr James Freeman, an Australian general practitioner based in Hobart, Tasmania, was reporting on the outcomes of people with hepatitis C who imported generic versions of direct-acting antivirals manufactured in India and elsewhere

NZers turn to generic Hepatitis C meds

New Zealanders with Hepatitis C are turning to generic, legally-imported treatments that cure the virus and give sufferers a new lease on life. Funded treatment for sufferers was recently made available in New Zealand, but only people with a particular strand of the virus - about half of all sufferers - can access it easily. Dunedin woman Hazel Heal lived with the virus for 30 years before taking generic medications last year. She has now been fully